FeesSafety
Pluang+

New trial data shows bezisterim improves symptoms in distinct Long COVID patient groups.

Market News
16 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
New trial data shows bezisterim improves symptoms in distinct Long COVID patient groups.

BioVie Inc. presented new Phase 2 trial data showing that bezisterim, an investigational drug, improves fatigue, cognition, and post-exertional malaise in two distinct biomarker-defined Long COVID patient groups. One group with high inflammation showed significant cognitive improvements, while another with low white blood cell counts experienced reduced fatigue and malaise. The trial also found bezisterim reduced neuropeptide Y, a biomarker linked to neuroimmune response, now prioritized by NIH for Long COVID research. These findings support a precision medicine approach for Long COVID treatment and guide future Phase 3 trials.

BioVie’s new biomarker data on Long COVID treatments is presented here with Pluang’s Health-sector market snapshot as of Nov 16, 2026 19:13 WIB: out of 150 priced US Health stocks tradable on Pluang, 67 rose and 61 fell today. Notable movers include Centene Corp (CNC) at USD 73.80 with a 3.55% gain and a typical hold time of 42 days, Brookdale Senior Living Inc. (BKD) at USD 8.85 down 3.49%, and Tango Therapeutics Inc. (TNGX) at USD 24.64 down 3.37%.

More News

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike is under pressure to clarify its cost-cutting plans as it prepares for its first investor day since 2017, scheduled for November 16–17. Despite efforts led by CEO Elliott Hill to turn the company around, management expects revenue to decline by ...

Market News
Bearish
55 minutes ago
Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric have partnered to create North America's first plug-and-play virtual power plant (VPP) for renters and apartment residents, starting in New York City. This innovative system uses portable power stations plugged into standar...

Market News
Bullish
1 hour ago
P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI has appointed retired Brigadier General Matt Isler as General Manager for its Aerospace and Defense division. Isler brings nearly 30 years of military and industry experience, including leadership roles at Northrop Grumman and startup DEFCON A...

Market News
Bullish
1 hour ago
Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo Inc. has renewed its Normal Course Issuer Bid (NCIB), allowing it to repurchase up to 22.5 million common shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's strategy to retur...

Company Fundamentals
Bullish
2 hours ago
GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian has launched the Enterprise Good Samaritan Program to identify and notify companies about high-impact leaked credentials that could expose their systems to attackers. Using AI and expert analysis, the program traces leaks to affected orga...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App